178 related articles for article (PubMed ID: 35881184)
1. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
Donners R; Figueiredo I; Westaby D; Koh DM; Tunariu N; Carreira S; de Bono JS; Fotiadis N
Cancer Imaging; 2023 Dec; 23(1):121. PubMed ID: 38102655
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing.
Donners R; Figueiredo I; Tunariu N; Blackledge M; Koh DM; de la Maza MLDF; Chandran K; de Bono JS; Fotiadis N
Eur Radiol; 2022 Jul; 32(7):4647-4656. PubMed ID: 35092476
[TBL] [Abstract][Full Text] [Related]
4. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes.
Chang IJ; Ilaslan H; Sundaram M; Schils J; Subhas N
Skeletal Radiol; 2018 May; 47(5):661-669. PubMed ID: 29218391
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6.
de Jong AC; Smits M; van Riet J; Fütterer JJ; Brabander T; Hamberg P; van Oort IM; de Wit R; Lolkema MP; Mehra N; Segbers M; van der Veldt AAM
J Nucl Med; 2020 Nov; 61(11):1607-1614. PubMed ID: 32169916
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Percutaneous CT-Guided Rib Biopsy.
Baffour FI; Moynagh MR; Eiken PW; Welch BT; Kurup AN; Atwell TD; Schmit GD
J Vasc Interv Radiol; 2019 Jan; 30(1):82-86. PubMed ID: 30527651
[TBL] [Abstract][Full Text] [Related]
8. CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.
Holmes MG; Foss E; Joseph G; Foye A; Beckett B; Motamedi D; Youngren J; Thomas GV; Huang J; Aggarwal R; Alumkal JJ; Beer TM; Small EJ; Link TM
J Vasc Interv Radiol; 2017 Aug; 28(8):1073-1081.e1. PubMed ID: 28549709
[TBL] [Abstract][Full Text] [Related]
9.
van Steenbergen TRF; Smits M; Scheenen TWJ; van Oort IM; Nagarajah J; Rovers MM; Mehra N; Fütterer JJ
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):147-154. PubMed ID: 31444628
[TBL] [Abstract][Full Text] [Related]
10. PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice?
Wu MH; Xiao LF; Liu HW; Yang ZQ; Liang XX; Chen Y; Lei J; Deng ZM
Cancer Imaging; 2019 Oct; 19(1):69. PubMed ID: 31665093
[TBL] [Abstract][Full Text] [Related]
11. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.
Kumar R; Mittal BR; Bhattacharya A; Vadi SK; Singh H; Bal A; Shukla J; Singh H; Sharma V; Sood A; Singh SK
Diagn Interv Imaging; 2020 Mar; 101(3):157-167. PubMed ID: 31722844
[TBL] [Abstract][Full Text] [Related]
13. Reduction of Radiation Dose and Scanning Time While Preserving Diagnostic Yield: A Comparison of Battery-Powered and Manual Bone Biopsy Systems.
Kihira S; Koo C; Lee A; Aggarwal A; Pawha P; Doshi A
AJNR Am J Neuroradiol; 2020 Mar; 41(3):387-392. PubMed ID: 32029464
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.
Spritzer CE; Afonso PD; Vinson EN; Turnbull JD; Morris KK; Foye A; Madden JF; Roy Choudhury K; Febbo PG; George DJ
Radiology; 2013 Dec; 269(3):816-23. PubMed ID: 23925271
[TBL] [Abstract][Full Text] [Related]
15.
Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Prakash G; Singh N
AJR Am J Roentgenol; 2019 Jan; 212(1):W10-W18. PubMed ID: 30383406
[TBL] [Abstract][Full Text] [Related]
16. CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.
Azar A; Garner HW; Rhodes NG; Yarlagadda B; Wessell DE
AJR Am J Roentgenol; 2021 Apr; 216(4):1022-1030. PubMed ID: 32755207
[No Abstract] [Full Text] [Related]
17. The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT.
Beheshti M; Vali R; Waldenberger P; Fitz F; Nader M; Hammer J; Loidl W; Pirich C; Fogelman I; Langsteger W
Mol Imaging Biol; 2009; 11(6):446-54. PubMed ID: 19326171
[TBL] [Abstract][Full Text] [Related]
18. Comparison of CT and PET/CT for biopsy guidance in oncological patients.
Cerci JJ; Tabacchi E; Bogoni M; Delbeke D; Pereira CC; Cerci RJ; Krauzer C; Sakamoto DG; Fanti S; Vitola JV
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1269-1274. PubMed ID: 28364161
[TBL] [Abstract][Full Text] [Related]
19. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy.
Leffler SG; Chew FS
AJR Am J Roentgenol; 1999 May; 172(5):1389-92. PubMed ID: 10227522
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Factors Potentially Influencing Diagnostic Yield Among Computed Tomography-Guided Biopsies for Bone Lesions.
Yoon GH; Gavilá ER; Wei J; Burke CJ; Walter WR
J Comput Assist Tomogr; 2022 Sep-Oct 01; 46(5):762-769. PubMed ID: 35723638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
